Health Care & Life Sciences » Biotechnology | GreenCross Labcell Corp.

GreenCross Labcell Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2014
2015
2016
2017
Net Income before Extraordinaries
1,667
2,260
2,328
1,057
Depreciation, Depletion & Amortization
454
531
607
706
Other Funds
1,333
1,004
262
2,488
Funds from Operations
3,454
3,796
3,197
4,251
Changes in Working Capital
757
2,308
3,493
1,390
Net Operating Cash Flow
2,697
1,488
297
2,861
Capital Expenditures
413
834
856
1,776
Sale of Fixed Assets & Businesses
28
-
-
42
Purchase/Sale of Investments
1,800
900
35,436
38,736
Net Investing Cash Flow
2,644
1,977
36,354
36,335
Cash Dividends Paid - Total
147
273
-
792
Net Financing Cash Flow
147
523
36,769
792
Net Change in Cash
94
35
118
38,405
Free Cash Flow
2,442
844
1,069
1,747
Other Sources
138
28
125
244
Change in Capital Stock
-
797
36,769
-
Other Uses
598
2,071
187
911

About GreenCross Labcell

View Profile
Address
4th Floor, Mokam Building
Yongin GY 16924
Korea, Republic Of
Employees -
Website http://www.gclabcell.com
Updated 09/14/2018
Green Cross Lab Cell Corp. engages in the provision of cord blood stem cell banking service. It operates through the following Businesses: Cell Therapy Products, Sample Test, Blood Banking, and Bio Logistics. The company was founded on June 21, 2011 and is headquartered in Yongin, South Korea.